Utah Medical Products Inc UTMD Q1 2024 Earnings EPS of 109 Reported Stock Gains Modestly DDL Q4 2025 Earnings Profitability Milestone Despite Mixed Market Signals FITBM Q1 2026 Earnings Preferred Stock EPS Surges Past Estimates on Strong Bank Performance CTEV Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses CSGS Q1 2026 Earnings Strong EPS Beat Amid Flat Market Reaction